|Immune self-reactivity triggered by drug-modified HLA-peptide repertoire|
PT Illing, JP Vivian, NL Dudek, L Kostenko, Z Chen, M Bharadwaj, ...
Nature 486 (7404), 554-558, 2012
|Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor|
R Reantragoon, L Kjer-Nielsen, O Patel, Z Chen, PT Illing, M Bhati, ...
Journal of Experimental Medicine 209 (4), 761-774, 2012
|Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex|
M Bharadwaj, P Illing, A Theodossis, AW Purcell, J Rossjohn, ...
Annual review of pharmacology and toxicology 52, 401-431, 2012
|Human CD8+ T cell cross-reactivity across influenza A, B and C viruses|
M Koutsakos, PT Illing, THO Nguyen, NA Mifsud, JC Crawford, S Rizzetto, ...
Nature immunology 20 (5), 613-625, 2019
|Human leukocyte antigen-associated drug hypersensitivity|
PT Illing, JP Vivian, AW Purcell, J Rossjohn, J McCluskey
Current opinion in immunology 25 (1), 81-89, 2013
|A subset of HLA-I peptides are not genomically templated: Evidence for cis-and trans-spliced peptide ligands|
P Faridi, C Li, SH Ramarathinam, JP Vivian, PT Illing, NA Mifsud, R Ayala, ...
Science immunology 3 (28), 2018
|MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape|
P Pymm, PT Illing, SH Ramarathinam, GM O'Connor, VA Hughes, ...
Nature structural & molecular biology 24 (4), 387-394, 2017
|Constitutive and inflammatory immunopeptidome of pancreatic β-cells|
NL Dudek, CT Tan, DG Gorasia, NP Croft, PT Illing, AW Purcell
Diabetes 61 (11), 3018-3025, 2012
|The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions|
PT Illing, AW Purcell, J McCluskey
Immunogenetics 69 (8), 617-630, 2017
|Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions|
PT Illing, NA Mifsud, AW Purcell
Current opinion in immunology 42, 31-40, 2016
|The cellular redox environment alters antigen presentation|
JA Trujillo, NP Croft, NL Dudek, R Channappanavar, A Theodossis, ...
Journal of Biological Chemistry 289 (40), 27979-27991, 2014
|The molecular basis for peptide repertoire selection in the human leukocyte antigen (HLA) C* 06: 02 molecule|
JI Mobbs, PT Illing, NL Dudek, AG Brooks, DG Baker, AW Purcell, ...
Journal of Biological Chemistry 292 (42), 17203-17215, 2017
|A comprehensive analysis of peptides presented by HLA‐A1|
K Giam, R Ayala‐Perez, PT Illing, RB Schittenhelm, NP Croft, AW Purcell, ...
Tissue Antigens 85 (6), 492-496, 2015
|Downregulation of MHC class I expression by influenza a and B viruses|
M Koutsakos, HEG McWilliam, TE Aktepe, S Fritzlar, PT Illing, NA Mifsud, ...
Frontiers in immunology 10, 1158, 2019
|Personalized medicine for HLA-associated drug-hypersensitivity reactions|
M Bharadwaj, P Illing, L Kostenko
Personalized medicine 7 (5), 495-516, 2010
|HLA‐associated antiepileptic drug‐induced cutaneous adverse reactions|
KA Mullan, A Anderson, PT Illing, P Kwan, AW Purcell, NA Mifsud
Hla 93 (6), 417-435, 2019
|HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome|
PT Illing, P Pymm, NP Croft, HG Hilton, V Jojic, AS Han, JL Mendoza, ...
Nature communications 9 (1), 1-13, 2018
|Identification of Native and Posttranslationally Modified HLA‐B* 57: 01‐Restricted HIV Envelope Derived Epitopes Using Immunoproteomics|
SH Ramarathinam, S Gras, S Alcantara, AWS Yeung, NA Mifsud, S Sonza, ...
Proteomics 18 (12), 1700253, 2018
|Employing proteomics in the study of antigen presentation: an update|
SH Ramarathinam, NP Croft, PT Illing, P Faridi, AW Purcell
Expert review of proteomics 15 (8), 637-645, 2018
|Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA‐B* 57: 01 binding and T‐cell activation|
PJ Thomson, PT Illing, J Farrell, M Alhaidari, CC Bell, N Berry, PM O’Neill, ...
Allergy 75 (3), 636-647, 2020